News & Events

Wall Street Journal: Biotech Startup Werewolf Therapeutics Hunts Down $56 Million

Biotechnology startup Werewolf Therapeutics Inc. gathered $56 million in venture financing to seek solutions to problems that have hindered a promising type of cancer immunotherapy.

Read the full story

Wall Street Journal

By Brian Gormley